108 related articles for article (PubMed ID: 37816258)
1. RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.
Zhang B; Sun R; Gu M; Jiang Z; Wang Y; Zhang L; Liu X; Chi Z
Biochem Cell Biol; 2024 Feb; 102(1):60-72. PubMed ID: 37816258
[TBL] [Abstract][Full Text] [Related]
2. USP44 accelerates the growth of T-cell acute lymphoblastic leukemia through interacting with WDR5 and repressing its ubiquitination.
Chi Z; Zhang B; Sun R; Wang Y; Zhang L; Xu G
Int J Med Sci; 2022; 19(14):2022-2032. PubMed ID: 36483601
[TBL] [Abstract][Full Text] [Related]
3. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
4. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-138-5p protects the early diabetic retinopathy by regulating NOVA1.
Bao XY; Cao J
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7749-7756. PubMed ID: 31599400
[TBL] [Abstract][Full Text] [Related]
6. NOVA1 acts on Impact to regulate hypothalamic function and translation in inhibitory neurons.
Tajima Y; Ito K; Yuan Y; Frank MO; Saito Y; Darnell RB
Cell Rep; 2023 Feb; 42(2):112050. PubMed ID: 36716149
[TBL] [Abstract][Full Text] [Related]
7. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
[TBL] [Abstract][Full Text] [Related]
8. NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.
Yu X; Zheng H; Chan MTV; Wu WKK
J Cell Mol Med; 2018 May; 22(5):2622-2630. PubMed ID: 29498217
[TBL] [Abstract][Full Text] [Related]
9. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.
Saito Y; Yang Y; Saito M; Park CY; Funato K; Tabar V; Darnell RB
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2314695121. PubMed ID: 38416679
[TBL] [Abstract][Full Text] [Related]
10. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
11. Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer.
Zhou H; Yang L; Lin X; Chan TF; Lee NP; Tse WKF; Zhang X; Li R; Lai KP
Aging (Albany NY); 2023 May; 15(10):4304-4318. PubMed ID: 37204480
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the
Fu RH; Chen HJ; Hong SY
Cells; 2023 Oct; 12(20):. PubMed ID: 37887320
[No Abstract] [Full Text] [Related]
13. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J
BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618
[TBL] [Abstract][Full Text] [Related]
14. Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.
Kim EK; Yoon SO; Kim SH; Yang WI; Cho YA; Kim SJ
J Pathol Transl Med; 2016 Mar; 50(2):104-12. PubMed ID: 26922803
[TBL] [Abstract][Full Text] [Related]
15. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 44 inhibits cell growth by suppressing AKT signaling in non-small cell lung cancer.
Zhang YK; Tian WZ; Zhang RS; Zhang YJ; Ma HT
Kaohsiung J Med Sci; 2019 Sep; 35(9):535-541. PubMed ID: 31197957
[TBL] [Abstract][Full Text] [Related]
17. Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis.
Bao ZY; Li HM; Zhang SB; Fei YQ; Yao MF; Li LJ
Acta Pharmacol Sin; 2023 Nov; 44(11):2201-2215. PubMed ID: 37433872
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV.
Ratti A; Fallini C; Colombrita C; Pascale A; Laforenza U; Quattrone A; Silani V
J Biol Chem; 2008 Mar; 283(12):7531-41. PubMed ID: 18218628
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
20. USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model.
Lin YH; Forster M; Liang Y; Yu M; Wang H; Robert F; Langlais D; Pelletier J; Clare S; Nijnik A
Exp Hematol; 2019 Apr; 72():1-8. PubMed ID: 30639577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
